Engineered to scale bioprocessing operations into commercial manufacturing, the scale-X™ nitro controller delivers flexible, low-footprint, and cost-effective automation for vaccine and viral vectors production.
Integrating 200m² and 600m² scale-X nitro bioreactors, the new controller, as part of the scale-X platform, enables high productivity.
With its compact and optimized design, the scale-X nitro controller allows for rapid deployment in diverse environments while maintaining maximum operational flexibility. It delivers precision automation, ensuring high performance, reliability, and productivity for commercial-scale biomanufacturing.
